SI1720853T1 - Nova polimorfna oblika imatinibijevega mesilata in postopek za njeno pripravo - Google Patents

Nova polimorfna oblika imatinibijevega mesilata in postopek za njeno pripravo

Info

Publication number
SI1720853T1
SI1720853T1 SI200432299T SI200432299T SI1720853T1 SI 1720853 T1 SI1720853 T1 SI 1720853T1 SI 200432299 T SI200432299 T SI 200432299T SI 200432299 T SI200432299 T SI 200432299T SI 1720853 T1 SI1720853 T1 SI 1720853T1
Authority
SI
Slovenia
Prior art keywords
preparation
polymorphic form
imatinib mesylate
novel polymorphic
novel
Prior art date
Application number
SI200432299T
Other languages
English (en)
Inventor
Kompella Natco Pharma Limited AMALA
Rao Thungathurthi Natco Pharma Limited Srinivasa
Kali Satya Bhujanga Rao Natco Pharma Limited Adibhatla
Sreenivas Natco Pharma Limited RACHAKONDA
Chowdary Nannapaneni Natco Pharma Ltd. Venkaiah
Khadgapathi Natco Pharma Limited Podili
Original Assignee
Natco Pharma Limited "Natco House
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34856856&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1720853(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Natco Pharma Limited "Natco House filed Critical Natco Pharma Limited "Natco House
Publication of SI1720853T1 publication Critical patent/SI1720853T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200432299T 2004-02-11 2004-11-16 Nova polimorfna oblika imatinibijevega mesilata in postopek za njeno pripravo SI1720853T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN105CH2004 2004-02-11
PCT/IN2004/000352 WO2005077933A1 (en) 2004-02-11 2004-11-16 Novel polymorphic form of imatinib mesylate and a process for its preparation
EP04806748.2A EP1720853B2 (en) 2004-02-11 2004-11-16 Pharmaceutical compositions of the 2 crystalline form of imatinib mesylate for use in the treatment of chronic myelogenous leukemia

Publications (1)

Publication Number Publication Date
SI1720853T1 true SI1720853T1 (sl) 2016-04-29

Family

ID=34856856

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200432299T SI1720853T1 (sl) 2004-02-11 2004-11-16 Nova polimorfna oblika imatinibijevega mesilata in postopek za njeno pripravo

Country Status (10)

Country Link
US (1) US8048883B2 (sl)
EP (1) EP1720853B2 (sl)
CA (1) CA2555804C (sl)
DK (1) DK1720853T3 (sl)
ES (1) ES2565078T3 (sl)
HU (1) HUE028884T2 (sl)
PL (1) PL1720853T3 (sl)
PT (1) PT1720853E (sl)
SI (1) SI1720853T1 (sl)
WO (1) WO2005077933A1 (sl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
PL1720853T3 (pl) 2004-02-11 2016-06-30 Natco Pharma Ltd Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania
TR200701870T1 (tr) * 2004-09-02 2007-05-21 Cipla Limited İmatinib mesilatın kararlı kristal formu ve bu formun hazırlanması için işlem.
WO2006048890A1 (en) * 2004-11-04 2006-05-11 Sun Pharmaceutical Industries Limited Imatinib mesylate crystal form and process for preparation thereof
WO2006054314A1 (en) * 2004-11-17 2006-05-26 Natco Pharma Limited Polymorphic forms of imatinib mesylate
EP1922314A1 (en) * 2005-08-26 2008-05-21 Novartis AG Delta and epsilon crystal forms of imatinib mesylate
EP1960380A1 (en) 2005-11-25 2008-08-27 Novartis AG F,g,h,i and k crystal forms of imatinib mesylate
US8067421B2 (en) 2006-04-27 2011-11-29 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
US7977348B2 (en) 2006-04-27 2011-07-12 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
EP1919893A2 (en) 2006-04-27 2008-05-14 Sicor, Inc. Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
EP1988089A1 (en) 2006-10-26 2008-11-05 Sicor, Inc. Imatinib base, and imatinib mesylate and processes for preparation thereof
KR101041203B1 (ko) * 2007-09-25 2011-06-13 테바 파마슈티컬 인더스트리즈 리미티드 안정한 이매티닙 조성물
US7947699B2 (en) 2008-01-10 2011-05-24 Actavis Group Ptc Ehf Anhydrous amorphous imatinib mesylate
US20100330130A1 (en) 2009-05-22 2010-12-30 Actavis Group Ptc Ehf Substantially pure imatinib or a pharmaceutically acceptable salt thereof
CZ2009570A3 (cs) 2009-08-26 2011-03-09 Zentiva, K. S. Príprava, stabilizace a využití polymorfu imatinib mesylátu pro vývoj lékových forem
WO2011095835A1 (en) 2010-02-02 2011-08-11 Actavis Group Ptc Ehf Highly pure imatinib or a pharmaceutically acceptable salt thereof
BR112012020491A2 (pt) 2010-02-15 2017-10-10 Reliance Life Sciences Pvt Ltd processo para a preparação de forma alfa de mesilato de imatinib.
PL390611A1 (pl) 2010-03-04 2011-09-12 Tomasz Koźluk Sposób otrzymywania polimorficznej formy alfa i nowa forma polimorficzna mesylanu imatinibu
CA2792472A1 (en) * 2010-03-15 2011-09-22 Natco Pharma Limited Process for the preparation of highly pure crystalline imatinib base
EA024088B1 (ru) * 2010-06-18 2016-08-31 КРКА, д.д., НОВО МЕСТО α-ФОРМА МЕЗИЛАТА ИМАТИНИБА, СПОСОБЫ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ЕЁ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
CN102477031B (zh) * 2010-11-30 2015-07-15 浙江九洲药业股份有限公司 一种甲磺酸伊马替尼α晶型的制备方法
WO2012090221A1 (en) 2010-12-29 2012-07-05 Cadila Healthcare Limited Novel salts of imatinib
PL394169A1 (pl) 2011-03-09 2012-09-10 Adamed Spółka Z Ograniczoną Odpowiedzialnością Kompozycja farmaceutyczna metanosulfonianu imatinibu do napełniania jednostkowych postaci dawkowania oraz sposób jej wytwarzania
EP2691385A4 (en) 2011-03-31 2014-08-13 Ind Swift Lab Ltd IMPROVED METHOD FOR THE PRODUCTION OF IMATINIB AND ITS MESYLATE SALT
EP2604596A1 (en) * 2011-12-16 2013-06-19 Deva Holding Anonim Sirketi Polymorphs of imatinib
CN102584787B (zh) * 2012-01-19 2015-01-07 山东金城医药化工股份有限公司 甲磺酸伊马替尼晶体的超声制备方法
EP2817030A1 (en) 2012-02-21 2014-12-31 Ranbaxy Laboratories Limited Stable dosage forms of imatinib mesylate
WO2013136141A1 (en) 2012-03-13 2013-09-19 Fresenius Kabi Oncology Ltd. An improved process for the preparation of alpha form of imatinib mesylate
CA2877030A1 (en) 2012-06-22 2013-12-27 Basf Se Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
KR101242955B1 (ko) * 2012-06-25 2013-03-12 제일약품주식회사 이마티닙 메실레이트 결정형 α의 제조 방법
US9439903B2 (en) 2012-10-25 2016-09-13 Cadila Healthcare Limited Process for the preparation of amorphous imatinib mesylate
CA2914669C (en) * 2013-06-12 2017-05-09 Shilpa Medicare Limited Crystalline imatinib mesylate process
EA029062B9 (ru) * 2013-09-20 2018-05-31 Тютор С.А.С.И.Ф.И.А. Способ получения фармацевтической композиции и продукт способа
WO2015188243A1 (en) * 2014-06-10 2015-12-17 Cristália Produtos Químicos Farmacêuticos Ltda PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
WO2017078647A1 (en) 2015-11-05 2017-05-11 Koçak Farma Ilaç Ve Kimya Sanayi Anonim Şirketi Pharmaceutical compositions of imatinib
EA035891B1 (ru) 2016-01-25 2020-08-27 КРКА, д.д., НОВО МЕСТО Быстродиспергируемая фармацевтическая композиция, включающая ингибитор тирозинкиназы
AR111469A1 (es) 2017-04-21 2019-07-17 Yuhan Corp Sal de un compuesto del derivado de aminopiridina, una forma cristalina de la misma, y un proceso para preparar la misma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (sl) 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
ITMI992711A1 (it) † 1999-12-27 2001-06-27 Novartis Ag Composti organici
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
GB2398565A (en) 2003-02-18 2004-08-25 Cipla Ltd Imatinib preparation and salts
US7300938B2 (en) * 2003-06-02 2007-11-27 Hetero Drugs Limited Polymorphs of imatinib mesylate
PL1720853T3 (pl) 2004-02-11 2016-06-30 Natco Pharma Ltd Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania

Also Published As

Publication number Publication date
US20080255138A1 (en) 2008-10-16
ES2565078T3 (es) 2016-03-31
US8048883B2 (en) 2011-11-01
HUE028884T2 (en) 2017-01-30
PL1720853T3 (pl) 2016-06-30
CA2555804A1 (en) 2005-08-25
CA2555804C (en) 2012-06-26
EP1720853B1 (en) 2015-12-30
PT1720853E (pt) 2016-03-04
EP1720853B2 (en) 2023-06-28
EP1720853A1 (en) 2006-11-15
WO2005077933A1 (en) 2005-08-25
DK1720853T3 (en) 2016-03-29

Similar Documents

Publication Publication Date Title
PT1720853E (pt) Nova forma polimórfica de mesilato de imatinib e processo para a sua preparação
AU2003237596A1 (en) Novel polymorphs of imatinib mesylate
PL378128A1 (pl) Sposób wytwarzania imatinibu i imatinib wytworzony tym sposobem
IL180859A0 (en) Imatinib mesylate alpha form and production process therefor
IL180861A0 (en) Crystalline imatinib base and production process therefor
HK1093483A1 (en) Polymorphic form of n-
PL1802573T3 (pl) Proces syntezy 4-(3-metanosulfonylofenylo)-1-N-propylopiperydyny
IL183185A0 (en) Process of making crystalline aripiprazole
SI1740593T1 (sl) Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata
EP2176241A4 (en) NOVEL ERLOTINIB-FREE BASED MOISTURIZED FORM AND PROCESS FOR PREPARING THE ERLOTINIB HYDROCHLORIC HYDROCHL FORM A SUBSTANTIALLY FREE OF POLYMORPH FORM B
IL175514A0 (en) Polymorphic form b2 of ziprasidone base
PT2170844T (pt) Novos polimorfos de cloridrato de erlotinib e método de preparação
HUP0700604A3 (en) Novel processes for preparation of a 2h-chromene
IL172004A0 (en) Polymorphic forms of ziprasidone hci and processes for their preparation
IL175517A0 (en) Processes for preparation of ziprasidone
EP1773339A4 (en) CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE
IL191411A0 (en) Process for preparing pyridinamines and novel polymorphs thereof
IL197954A0 (en) Process for the preparation of imatinib and intermediates thereof
IL192360A0 (en) Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
EP1783162A4 (en) PROCESS FOR PRODUCING SUBMICRONIC STRUCTURES OF HONEYCOMB
IL163820A0 (en) Crystalline polymorphic form of irinotecan hydrochloride
IL175695A0 (en) Process for the preparation of valacyclovir hydrochloride
IL170350A (en) Method for preparing polymorphism of irinotecan hydrochloride
ZA200703495B (en) Process for the preparation of irbesartan hydrochloride
EP1791873A4 (en) NOVEL POLYMORPHIC FORM OF INULIN AND USES THEREOF